Tinnitus and Menopause: What Could Be Causing That Ringing in Your Ears

What Is Tinnitus and Why Does It Show Up at Menopause

Tinnitus is the medical term for hearing a sound, most often ringing, buzzing, hissing, clicking, or roaring, that has no source outside your body. It is not a disease itself but a symptom with a long list of possible causes. For women in their 40s and 50s, it often appears or worsens just as other perimenopausal symptoms ramp up, and that timing is not coincidental.

The inner ear, specifically the cochlea, is hormonally sensitive tissue. Estrogen receptors have been identified in the cochlea, the spiral ganglion neurons, and the auditory brainstem. When estrogen falls during perimenopause, those receptors lose their signal, which can change inner-ear fluid homeostasis, reduce cochlear blood flow, and alter how auditory nerves fire. The result for some women is a new or louder internal sound that was never there before.

What makes this stage of life particularly complicated is that menopause does not arrive alone. Thyroid disease, cardiovascular changes, anxiety, sleep disruption, and new medications all cluster at midlife, and every single one of those can independently cause tinnitus. Sorting out which factor is driving your symptom is the first clinical priority.

How Common Is Tinnitus in Perimenopausal and Postmenopausal Women

Tinnitus affects approximately 15% of the global adult population, but prevalence data broken down by menopausal status remain thin. Most large tinnitus trials have enrolled predominantly male subjects, a well-documented evidence gap. What smaller observational studies suggest is that women report a peak in new tinnitus onset during the perimenopausal years, and that this timing correlates with estrogen fluctuation rather than chronological age alone.

A 2020 study in the journal Menopause found that women with surgical menopause, whose estrogen drops abruptly rather than gradually, reported significantly higher rates of auditory symptoms compared with women in natural menopause, suggesting estrogen withdrawal speed matters, not just the final level.

The Estrogen-Cochlea Connection: What Is Actually Happening

Estrogen does several things in the inner ear that, when lost, can create the conditions for tinnitus.

Inner-Ear Fluid Balance

The cochlea operates in a precisely regulated fluid environment. Estrogen influences the sodium-potassium pumps that maintain the electrochemical gradient needed for normal sound transduction. Animal models show that estrogen deficiency disrupts endocochlear potential, the electrical charge inside the cochlear duct that powers hair cell function. Disrupted endocochlear potential means auditory signals become noisy and unreliable.

Cochlear Blood Flow

Estrogen is a vasodilator in the microvasculature. The stria vascularis, the blood-rich tissue that lines the cochlea and generates the endocochlear potential, depends on adequate perfusion. Reduced estrogen narrows cochlear microvessels, cutting oxygen delivery to hair cells. Hair cells under ischemic stress fire erratically, and the brain interprets that aberrant firing as sound.

Auditory Nerve Excitability

Estrogen also modulates GABA-A receptors in the central auditory pathway. Lower estrogen means less inhibitory tone in auditory processing circuits, so the nervous system becomes more sensitive to spontaneous neural firing. That heightened central sensitivity is one reason tinnitus in menopausal women is often described as more distressing rather than simply louder, because the emotional amplification loop tightens when inhibitory signaling weakens.

Other Causes That Mimic or Amplify Hormonal Tinnitus

Estrogen loss is a real contributor, but it should never be the only diagnosis you accept without ruling out other causes, some of which are more treatable.

Thyroid Dysfunction

Hypothyroidism is four to seven times more common in women than men and peaks in incidence between ages 40 and 60, exactly the perimenopausal window. Both underactive and overactive thyroid can cause tinnitus through different mechanisms: hypothyroidism via myxedematous fluid changes in the inner ear, hyperthyroidism via increased cardiac output and pulsatile blood flow. A TSH, free T4, and thyroid antibody panel is a necessary first step before attributing tinnitus to menopause.

Cardiovascular and Blood Pressure Changes

Hypertension accelerates in women after menopause. The SWAN (Study of Women's Health Across the Nation) cohort documented a significant rise in blood pressure in the two years surrounding the final menstrual period. High blood pressure causes pulsatile tinnitus, a rhythmic whooshing or throbbing that beats in time with the pulse. If your tinnitus has a pulse, blood pressure measurement and a vascular workup come first.

Noise-Induced and Age-Related Hearing Loss

Women are not immune to noise-induced hearing loss, though occupational exposure historically skewed male in studies. Age-related sensorineural hearing loss (presbycusis) affects both sexes starting in the 50s. Hearing loss is the single strongest predictor of tinnitus; the brain, deprived of external acoustic input in certain frequency ranges, generates phantom signals to fill the gap. An audiogram is essential.

Medications Common at Midlife

Several drug classes widely prescribed to perimenopausal women are ototoxic or tinnitus-associated:

• NSAIDs (ibuprofen, naproxen), taken for musculoskeletal pain or menstrual cramps, can cause reversible tinnitus at higher doses
• Loop diuretics (furosemide) used for fluid retention or hypertension
• Certain antidepressants, including SSRIs and SNRIs prescribed for hot flashes or mood, have tinnitus listed as a reported side effect in a minority of users
• Quinine-containing medications used for leg cramps
• High-dose aspirin, sometimes used for cardiovascular prevention

Review your full medication list with your prescriber if tinnitus appears or worsens after starting a new drug.

Anxiety, Sleep Disruption, and the Tinnitus Distress Loop

Perimenopause is a time of elevated anxiety and disrupted sleep for many women. Anxiety does not cause tinnitus in the structural sense, but it substantially amplifies tinnitus distress. The tinnitus distress model proposed by Jastreboff and refined by McKenna describes a feedback loop in which the limbic system and autonomic nervous system assign threat value to the tinnitus signal, making it more intrusive. Women with high perimenopausal anxiety scores consistently report higher tinnitus handicap inventory scores, even when the tinnitus intensity measured audiologically is similar to lower-anxiety peers.

Temporomandibular Joint (TMJ) Disorders

Bruxism and TMJ dysfunction increase during perimenopausal years, likely partly because of estrogen's role in joint laxity and partly because of sleep disruption driving jaw clenching. The TMJ sits immediately anterior to the ear canal, and somatic tinnitus originating from TMJ or cervical muscle tension is modulated by jaw movement or head position. If your tinnitus changes when you clench your teeth or turn your head, a dental or physical therapy evaluation is warranted.

How Tinnitus at Menopause Is Diagnosed

No single test confirms "menopausal tinnitus." The diagnosis is clinical and requires ruling out other causes systematically.

The Initial Workup

Your clinician should start with:

1. Full audiogram with pure-tone thresholds, speech discrimination, and tympanometry
2. Blood pressure measurement in both arms
3. Thyroid panel: TSH, free T4, TPO antibodies
4. Fasting metabolic panel: glucose, lipids, renal function (relevant because diabetes-related microvascular disease affects the cochlea)
5. CBC: anemia can cause tinnitus through reduced oxygen delivery
6. Medication review
7. Hormonal context: FSH and estradiol are not diagnostic for tinnitus but help establish menopausal stage

When Imaging Is Needed

The American Academy of Otolaryngology guideline on tinnitus recommends MRI of the internal auditory canals for unilateral tinnitus, asymmetric hearing loss, or tinnitus accompanied by neurologic symptoms. An acoustic neuroma (vestibular schwannoma) is rare but presents exactly this way and should not be attributed to menopause without imaging.

Red Flags That Need Same-Week Referral

• Tinnitus in one ear only
• Sudden hearing loss alongside tinnitus
• Tinnitus with vertigo (raises concern for Meniere's disease or perilymphatic fistula)
• Pulsatile tinnitus (requires vascular imaging)
• Any neurologic symptoms: facial numbness, weakness, or headache

Treatment Options: What the Evidence Actually Shows

The following framework organizes tinnitus treatment by the underlying driver, because a woman whose tinnitus stems from hypothyroidism needs levothyroxine, not sound therapy, as the primary intervention. Treating the correct mechanism first saves months of frustration.

Tier 1: Treat the identifiable cause

| Identified cause | First intervention | Evidence level | |---|---|---| | Hypothyroidism | Levothyroxine to normalize TSH | Strong; tinnitus often resolves | | Hypertension | Antihypertensive therapy + lifestyle | Moderate; pulsatile tinnitus improves | | Ototoxic medication | Dose reduction or switch with prescriber | Strong for reversible ototoxins | | Hearing loss | Hearing aids (restores masking input) | Strong; reduces central gain | | TMJ dysfunction | Occlusal splint, physical therapy | Moderate |

Tier 2: Address central sensitization and distress

Cognitive behavioral therapy (CBT) adapted for tinnitus is the intervention with the strongest evidence base for reducing tinnitus-related distress, with effect sizes maintained at 12-month follow-up. CBT does not make the sound quieter, but it reduces the threat-value the brain assigns to it, breaking the distress loop. A 2019 Cochrane review found CBT reduced tinnitus-specific distress compared to control conditions, though the evidence quality was graded moderate due to variability in protocols.

Sound therapy, including white noise generators and hearing aid masking programs, provides symptomatic relief for many women by reducing the contrast between the tinnitus and background acoustic environment. It works best when combined with CBT.

Tier 3: Hormonal considerations

The evidence for hormone replacement therapy (HRT) as a specific tinnitus treatment is preliminary. The 2020 Menopause journal study cited above found that women using systemic estrogen therapy reported lower tinnitus severity scores than non-users, but this was an observational finding, not a randomized controlled trial. No major guideline, including those from The Menopause Society, lists tinnitus as a primary indication for HRT.

If you are a perimenopausal woman with bothersome vasomotor symptoms, sleep disruption, and new tinnitus, and HRT is appropriate for your overall symptom burden and risk profile, it is reasonable to discuss whether auditory symptoms improve alongside other menopausal symptoms. A 12-week trial of HRT with documented tinnitus severity tracking is a clinically sensible approach for the right candidate.

What Does Not Work

• Ginkgo biloba: A large Cochrane review found no consistent evidence that ginkgo biloba reduces tinnitus compared to placebo. Avoid.
• Benzodiazepines: Provide short-term anxiolytic relief but no tinnitus improvement, carry dependency risk, and worsen sleep architecture in perimenopausal women.
• Dietary supplements marketed specifically for tinnitus: no RCT-level evidence supports zinc, magnesium, or B12 supplementation for tinnitus unless a documented deficiency is present.

Pregnancy, Postpartum, and Lactation: What Changes

Tinnitus during reproductive life stages is underrecognized and poorly studied in women.

Pregnancy

Tinnitus can appear or worsen in pregnancy due to:

• Plasma volume expansion of 40 to 50%, which increases cardiac output and can produce pulsatile tinnitus
• Gestational hypertension and preeclampsia: tinnitus with severe headache and visual changes in pregnancy is a medical emergency, not a normal pregnancy symptom
• Fluid retention affecting the inner ear, similar to the mechanism in Meniere's disease

Imaging for tinnitus workup in pregnancy: gadolinium-based MRI contrast agents are classified as Category C by the FDA and should be avoided in pregnancy unless the benefit clearly outweighs fetal risk. Non-contrast MRI is safe in pregnancy after the first trimester for evaluation of unilateral tinnitus when an acoustic neuroma is suspected.

Most ototoxic drugs, including aminoglycoside antibiotics and cisplatin, are contraindicated in pregnancy due to fetal ototoxicity risk. NSAIDs used for tinnitus-related pain should be avoided after 20 weeks due to fetal renal effects per ACOG guidance.

Postpartum and Lactation

Postpartum thyroiditis occurs in 5 to 10% of women in the first year after delivery and can present as hyperthyroid (weeks 2 to 10) then hypothyroid (weeks 10 to 20). Both phases can cause tinnitus. Postpartum thyroid screening with TSH is warranted in any woman with new tinnitus in the year after delivery, especially with a personal or family history of thyroid disease.

For breastfeeding women with tinnitus requiring treatment: CBT and sound therapy have no lactation concerns. Levothyroxine for hypothyroidism is safe in breastfeeding. Most ototoxic drugs should be avoided, though a lactation pharmacist or LactMed consultation via the NIH LactMed database should guide individual decisions. Benzodiazepines pass into breast milk and should be avoided.

Who This Is Right for and Who Should Look Further

Women Most Likely to Have Hormonally Mediated Tinnitus

• Perimenopause or recent surgical menopause, especially abrupt estrogen withdrawal
• Tinnitus appeared or worsened alongside other vasomotor symptoms (hot flashes, night sweats)
• Normal audiogram or only mild symmetric high-frequency loss
• Normal thyroid, blood pressure, and metabolic panel
• No new ototoxic medications
• Bilateral, non-pulsatile, high-pitched ringing

Women Who Need a Different or Additional Workup

• Tinnitus in one ear only: ENT referral within days
• Pulsatile tinnitus: vascular imaging and blood pressure workup
• Tinnitus with vertigo, hearing loss, or ear fullness: rule out Meniere's disease or acoustic neuroma
• New tinnitus after starting any medication: medication review first
• New tinnitus with fatigue, weight gain, cold intolerance: thyroid panel before attributing to menopause
• Tinnitus during pregnancy with headache or visual changes: immediate obstetric evaluation for preeclampsia

Living With Tinnitus at Midlife: Practical Steps

If you have worked through the diagnostic checklist and tinnitus persists, these evidence-based strategies help most women:

Sleep hygiene matters more than it sounds. Sleep deprivation raises central auditory gain, meaning the same tinnitus signal is processed as louder after a poor night. CBT for insomnia (CBT-I) has been shown to reduce tinnitus distress in women with comorbid sleep problems, likely by reducing this central gain. Address the sleep disruption directly, not just with sedatives.

Use sound enrichment at night. A fan, pink noise app, or nature sounds at low volume reduce the acoustic contrast that makes tinnitus most intrusive in a quiet bedroom. Keep volume well below 60 dB to avoid adding noise-induced hearing loss to the problem.

Limit caffeine and alcohol as a timed experiment. Some women report that caffeine or alcohol temporarily worsens tinnitus. The evidence is inconsistent at the population level, but a personal 3-week elimination trial costs nothing.

Protect the hearing you have. The National Institute on Deafness and Other Communication Disorders recommends hearing protection for any noise exposure above 85 dB. Lawn mowers, concerts, power tools, and earbuds at maximum volume all qualify. Hearing loss is the top tinnitus risk factor, and protecting cochlear hair cells is far more effective than any supplement.

Ask for a referral to a tinnitus specialist. An audiologist trained in tinnitus retraining therapy (TRT) or a psychologist trained in tinnitus-focused CBT provides the most targeted care. Primary care can manage the workup but rarely has the bandwidth for the full counseling component.